Tissue specificity of DNA repair: the CRISPR compass
Joana Ferreira da Silva1, Mathilde Meyenberg1, Joanna I Loizou1
1CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria; Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria.
Abstract:
CRISPR-Cas9-mediated genome editing holds great promise for the correction of pathogenic variants in humans. However, its therapeutic implementation is hampered due to unwanted editing outcomes. A better understanding of cell type- and tissue-specific DNA repair processes will ultimately enable precise control of editing outcomes for safer and effective therapies.
Related Concept Videos
Homologous Recombination
CRISPR/Cas9 Genome Editing
CRISPR
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Overview of DNA Repair
Overview of DNA Repair
Chemically...


